Shanghai Bio-heart Biological Technology Co Ltd

02185

Company Profile

  • Business description

    Shanghai Bio-heart Biological Technology Co Ltd is engaged in the research and development of bioresorbable scaffold (BRS) products and the renal denervation (RDN) system. The company is a interventional cardiovascular device company in China, and locate in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies, bioresorbable scaffolds (BRS) and renal denervation (RDN), addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension. Currently, the portfolio has three product candidates in various stages of clinical development.

  • Contact

    No.590 Ruiqing Road
    Room 302, 3rd Floor, Building 4 & Building 6
    East Zhangjiang Hi-Tech Park
    Pudong New Area
    Shanghai
    CHN

    T: +86 2168798511

    http://www.bio-heart.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    65

Stocks News & Analysis

stocks

Investors cheer Guzman dialing back global ambitions

Our view after US restaurants are closed.
stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.
stocks

Poor organic growth obscured by acquisition for ASX listed share

Sales dropped by 2% without impact of acquisition.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,866.4036.70-0.41%
CAC 408,258.26142.511.76%
DAX 4025,389.10500.542.01%
Dow JONES (US)50,579.70294.040.58%
FTSE 10010,466.2622.790.22%
HKSE25,606.03219.510.86%
NASDAQ26,343.9750.870.19%
Nikkei 22564,848.46309.73-0.48%
NZX 50 Index13,078.18107.900.83%
S&P 5007,473.4727.750.37%
S&P/ASX 2008,638.4038.20-0.44%
SSE Composite Index4,112.9035.620.87%

Market Movers